The role of optimal control in assessing the most cost-effective implementation of a vaccination programme: HPV as a case study

Mathematical Biosciences

Volumn 231, Issue 2, 2011, Pages 126-134

  Brown, V L ^a   Jane White, K A ^a  

^a University of Bath   (United Kingdom)

Author keywords

Mathematical model; Public health policy; Sexually transmitted infection

Indexed keywords

CONTROL MODEL; HUMAN PAPILLOMAVIRUS; IS COSTS; OPTIMAL CONTROL MODEL; OPTIMAL CONTROL SOLUTION; OPTIMAL CONTROLS; PUBLIC HEALTH POLICY; SEXUALLY TRANSMITTED INFECTION; STEADY STATE; VACCINATION STRATEGY;

CONTROL; COST EFFECTIVENESS; DISEASE CONTROL; OPTIMIZATION;

MATHEMATICAL MODELS;

WART VIRUS VACCINE;

DISEASE CONTROL; NUMERICAL MODEL; PUBLIC HEALTH; SEXUALLY TRANSMITTED DISEASE; VACCINATION; VIRUS;

ARTICLE; CASE STUDY; CLINICAL ASSESSMENT; COMPARTMENT MODEL; CONTROLLED STUDY; COST CONTROL; COST EFFECTIVENESS ANALYSIS; COST MINIMIZATION ANALYSIS; FEMALE; HEALTH CARE PLANNING; HEALTH CARE POLICY; HEALTH PROGRAM; HUMAN; INFECTION CONTROL; INFECTION PREVENTION; INFECTION SENSITIVITY; MALE; MASS IMMUNIZATION; PAPILLOMAVIRUS INFECTION; PROCESS OPTIMIZATION; PUBLIC HEALTH SERVICE; QUALITY CONTROL; SEXUAL BEHAVIOR; SEXUALLY TRANSMITTED DISEASE; WART VIRUS;

ADOLESCENT; CHILD; COST-BENEFIT ANALYSIS; FEMALE; HUMANS; MALE; MODELS, ECONOMIC; NUMERICAL ANALYSIS, COMPUTER-ASSISTED; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; PAPILLOMAVIRUS VACCINES; UTERINE CERVICAL NEOPLASMS; VACCINATION;

UNITED KINGDOM;

HUMAN PAPILLOMAVIRUS;

EID: 79954908956     PISSN: 00255564     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mbs.2011.02.009     Document Type: Article

References (28)

1. Trottier H., Franco E.L. The epidemiology of genital human papillomavirus infection. Vaccine 2006, 24(Suppl 1):4. 10.1016/j.vaccine.2005.09.054.
2. Jain N., Euler G.L., Shefer A., Lu P., Yankey D., Markowitz L. Human papillomavirus (HPV) awareness and vaccination initiation among women in the United States, National Immunization Survey-Adult 2007. Prev. Med. 2009, 48:426. 10.1016/j.ypmed.2008.11.010.
3. Adams M., Jasani B., Fiander A. Human papillomavirus (HPV) prophylactic vaccination: challenges for public health and implications for screening. Vaccine 2007, 25:3007. 10.1016/j.vaccine.2007.01.016.
4. Goldie S.J., Goldhaber-Fiebert J.D., Garnett G.P. Chapter 18: Public Health policy for cervical cancer prevention; the role of decision science, economic evaluation and mathematical modelling. Vaccine 2006, 24(Suppl 3):155. 10.1016/j.vaccine.2006.05.112.
5. Newall A.T., Beutals P., Wood J.G., Edmunds W.J., MacIntyre C.R. Cost-effectiveness analyses of human papillomavirus vaccination. Lancet 2007, 7:289.
6. Goldie S.J., Kim J.J., Myers E. Chapter 19: cost-effectiveness of cervical cancer screening. Vaccine 2006, 24(Suppl 3):164. 10.1016/j.vaccine.2006.05.114.
7. Sethi S.P., Staats P.W. Optimal control of some simple deterministic epidemic models. J. Oper. Res. Soc. 1978, 29(2):129.
8. Behncke H. Optimal control of deterministic epidemics. Optim. Control Appl. Meth. 2000, 21:269.
9. Ögren P., Martin C.F. Vaccination strategies for epidemics in highly mobile populations. Appl. Math. Comput. 2002, 127:261. 10.1016/S0096-3003(01)00004-2.
10. Lenhart S., Workman J.T. Optimal Control Applied to Biological Models 2007, Chapman and Hall/CRC, Boca Raton.
11. Kohli M., Ferko N., Martin A., Franco E.L., Jenkins D., Gallivan S., Sherlaw-Johnson C., Drummond M. Estimating the long-term impact of a prophylactic human papillomavirus 16/18 vaccine on the burden of cervical cancer in the UK. Br. J. Cancer 2007, 96:143.
12. Taira A.V., Neukermans C.P., Sanders G.D. Evaluating human papillomavirus vaccination programs. Emerg. Infect. Dis. 2004, 10:1915.
13. Elbasha E.H., Galvani A.P. Vaccination against multiple HPV types. Math. Biosci. 2005, 197:88. 10.1016/j.mbs.2005.05.004.
14. National Centre for Social Research et al. National Survey of Sexual Attitudes and Lifestyles II, 2000-2001 [computer file]. Colchester, Essex: UK Data Archive [distributor], August 2005. SN:5223.
15. Peto J., Gilham C., Deacon J., Taylor C., Evans C., Binns W., Haywood M., Elanko N., Coleman D., Yule R., Desai M. Cervical HPV infection and neoplasia in a large population-based prospective study: the Manchester cohort. Br. J. Cancer 2004, 91:942.
16. Yan X., Zou Y. Optimal and sub-optimal quarantine and isolation control in SARS epidemics. Math. Comput. Model. 2008, 47:235. 10.1016/j.mcm.2007.04.003.
17. Zaman G., Kang Y.H., Jung I.H. Stability analysis and optimal vaccination of an SIR epidemic model. Biosystems 2008, 93:240. 10.1016/j.biosystems.2008.05.004.
18. Jit M., Choi Y.H., Edmunds W.J. Economic evaluation of human papillomavirus vaccination in the United Kingdom. Br. Med. J. 2008, 337:331.
19. Goldie S.J., Kohli M., Grima D., Weinstein M.C., Wright T.C., Bosch F.X., Franco E. Projected clinical benefits and cost-effectiveness of a human papillomavirus 16/18 vaccine. J. Natl. Cancer Inst. 2004, 96(8):604.
20. National Health Service website, Reviewed September 2009, Can genital HPV infection be treated? http://www.nhs.uk/chq/Pages/2383.aspx.
21. Sanders G.D., Taira A.V. Cost effectiveness of a potential vaccine for human papillomavirus. Emerg. Infect. Dis. 2003, 9(1):37.
22. Leggatt G.R., Frazer I.H. HPV vaccines: the beginning of the end for cervical cancer. Curr. Opin. Immunol. 2007, 19:232. 10.1016/j.coi.2007.01.004.
23. National Statistics Online, Published 7 May 2004. http://www.statistics.gov.uk/cci/nugget.asp?id=881.
24. National Statistics Online, Published February 2006. http://www.statistics.gov.uk/CCI/nugget.asp?ID=411&Pos=&ColRank=2&Rank=1000.
25. Burchall A.N., Winer R.L., de Sanjosé S., Franco E.L. Chapter 6: epidemiology and transmission dynamics of genital HPV infection. Vaccine 2006, 24(Suppl 3):52. 10.1016/j.vaccine.2006.05.031.
26. Pontryagin L.S., Boltyanskii V.G., Gamkrelidze R.V., Mischenko E.F. The Mathematical theory of optimal Processes 1962, Interscience, New York.
27. Fleming W.H., Rishel R.W. Deterministic and Stochastic Optimal Control 1975, Springer Verlag, New York.
28. Lukes D.L. Differential Equations: Classical to Controlled, Mathematics in Science and Engineering 1982, Academic Press, New York.